바이오마커 시장 : 규모, 점유율, 동향, 산업 분석 - 유형별, 연구 분야별, 기술별, 질환 적응증별, 용도별, 지역별 시장 예측(2025-2034년)

Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Region - Market Forecast, 2025-2034

US $ 4,250 ￦ 5,960,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250 ￦ 7,362,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250 ￦ 8,765,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

Polaris Market Research의 최신 조사에 따르면 바이오마커 시장 규모는 2034년까지 1,467억 8,000만 달러에 이를 것으로 예측됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

세계의 바이오마커 시장은 임상 진단, 제약 연구, 건강 모니터링 등의 각 공정에서 이용이 확대되고 있으며, 확대를 계속하고 있습니다. 단백질, 유전자, 대사산물 분석과 같은 바이오마커는 건강 상태와 질병의 유무를 측정하는 생물학적 지표 역할을 합니다. 혈액, 조직, 소변 등의 샘플은 일반적으로 의료 및 연구 목적으로 이러한 지표를 분석하기 위해 실험실에서 사용됩니다.

바이오마커의 채용은 병원, 진단 실험실, 연구센터의 일반적인 건강 평가와 고급 임상 평가에서 증가하고 있습니다. 임상 워크플로우를 개선하고 보다 많은 정보를 바탕으로 의료 의사 결정을 지원하는 바이오마커의 역할은 실험실 기술이 보다 정교하고 사용하기 쉬워짐에 따라 계속 확대되고 있습니다.

바이오마커 시장 보고서 하이라이트

연구 분야별로는 유전적 변이의 검출, 질병 감수성의 평가, 치료 영역 전체에 걸친 정밀의료 접근의 실현에 있어서 광범위한 용도에 의해 유전체학 분야가 2024년 시장에서 주도적 지위를 차지했습니다.

기술 측면에서 차세대 시퀀싱 기술은 예측 기간 동안 가장 급속한 시장 확대를 이룰 것으로 예측됩니다. 이러한 성장의 가속화는 종합적인 바이오마커 탐색을 촉진하는 높고처리량 유전체 분석을 위한 NGS의 탁월한 능력을 반영합니다.

북미는 2024년에 바이오마커 시장에서 가장 큰 점유율을 획득했는데, 이는 이 지역에 혁신적인 바이오제약기업, 첨단진단연구소가 집중하고 있으며, 정밀의료 연구개발 이니셔티브에 상당한 투자가 이루어지고 있음에 뒷받침되고 있습니다.

아시아태평양의 바이오마커 시장은 헬스케어 인프라의 급속한 개선, 첨단 진단기술의 채용 확대, 신흥경제권에서의 생물의학연구능력의 확대가 견인하며, 예측 기간 중 가장 높은 성장률을 보일 것으로 예측됩니다.

세계 주요 시장 진출 기업은 Abbott Laboratories, Agilent Technologies, Inc., BioMerieux SA, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Guardant Health, Inc., Allumina NV, Revvity, Inc. 등이 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 바이오마커 시장 인사이트

• 시장 현황
• 바이오마커 시장 역학
  • 성장 촉진요인 및 기회
    • 만성질환의 유병률 상승
    • 유전체학 및 단백질체학의 진보
  • 성장 억제요인 및 과제
    • 바이오마커 검증 및 개발 고비용
    • 규제 불확실성 및 장기적인 승인 프로세스
• PESTEL 분석
• 바이오마커 시장 동향
• 밸류체인 분석

제5장 세계의 바이오마커 시장 : 유형별

• 주요 조사 결과
• 서문
• 안전성 바이오마커
• 유효성 바이오마커
• 검증 바이오마커

제6장 세계의 바이오마커 시장 : 연구 분야별

• 주요 조사 결과
• 서문
• 유전체학
• 단백질체학
• 대사체학
• 기타 연구분야

제7장 세계의 바이오마커 시장 : 기술별

• 주요 조사 결과
• 서문
• 면역 측정
• 차세대 시퀀싱(NGS)
• 중합효소 연쇄반응(PCR)
• 질량 분석
• 크로마토그래피
• 기타 기술

제8장 세계의 바이오마커 시장 : 질환 적응증별

• 주요 조사 결과
• 서문
• 암
• 감염증
• 면역 질환
• 정부 및 공공 부문
• 신경질환
• 심혈관 질환
• 기타 질환 적응증

제9장 세계의 바이오마커 시장 : 용도별

• 주요 조사 결과
• 서문
• 임상 진단
• 의약품 발견 및 개발
• 맞춤형 의료
• 임상 조사
• 기타 용도

제10장 세계의 바이오마커 시장 : 지역별

• 주요 조사 결과
• 서문
  • 바이오마커 시장 평가 : 지역별(2020-2034년)
• 북미
  • 북미 : 유형별(2020-2034년)
  • 북미 : 연구 분야별(2020-2034년)
  • 북미 : 기술별(2020-2034년)
  • 북미 : 질환 적응증별(2020-2034년)
  • 북미 : 용도별(2020-2034년)
  • 미국
  • 캐나다
• 유럽
  • 유럽 : 유형별(2020-2034년)
  • 유럽 : 연구 분야별(2020-2034년)
  • 유럽 : 기술별(2020-2034년)
  • 유럽 : 질환 적응증별(2020-2034년)
  • 유럽 : 용도별(2020-2034년)
  • 영국
  • 프랑스
  • 독일
  • 이탈리아
  • 스페인
  • 네덜란드
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 아시아태평양 : 유형별(2020-2034년)
  • 아시아태평양 : 연구 분야별(2020-2034년)
  • 아시아태평양 : 기술별(2020-2034년)
  • 아시아태평양 : 질환 적응증별(2020-2034년)
  • 아시아태평양 : 용도별(2020-2034년)
  • 중국
  • 인도
  • 말레이시아
  • 일본
  • 인도네시아
  • 한국
  • 호주
  • 기타 아시아태평양
• 중동 및 아프리카
  • 중동 및 아프리카 : 유형별(2020-2034년)
  • 중동 및 아프리카 : 연구 분야별(2020-2034년)
  • 중동 및 아프리카 : 기술별(2020-2034년)
  • 중동 및 아프리카 : 질환 적응증별(2020-2034년)
  • 중동 및 아프리카 : 용도별(2020-2034년)
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 남아프리카
  • 기타 중동 및 아프리카
• 라틴아메리카
  • 라틴아메리카 : 유형별(2020-2034년)
  • 라틴아메리카 : 연구 분야별(2020-2034년)
  • 라틴아메리카 : 기술별(2020-2034년)
  • 라틴아메리카 : 질환 적응증별(2020-2034년)
  • 라틴아메리카 : 용도별(2020-2034년)
  • 멕시코
  • 브라질
  • 아르헨티나
  • 기타 라틴아메리카

제11장 경쟁 구도

• 확대 및 인수 분석
  • 확대
  • 인수
• 제휴, 협업, 합의 및 공개

제12장 기업 프로파일

• Abbott Laboratories
• Agilent Technologies, Inc.
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Charles River Laboratories International, Inc.
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd
• Guardant Health, Inc.
• Illumina, Inc.
• Merck KGaA
• QIAGEN NV
• Revvity, Inc.

AJY

영문 목차

영문목차

The biomarkers market size is expected to reach USD 146.78 Billion by 2034, according to a new study by Polaris Market Research. The report "Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global biomarkers market continues to expand due to its growing use across clinical diagnostics, pharmaceutical research, and health monitoring processes. Biomarkers such as proteins, genes, and metabolites assays serve as biological indicators to measure health status or disease presence. Samples such as blood, tissue, and urine are typically used in laboratory settings to analyze these indicators for medical or research purposes.

The adoption of biomarkers is increasing in general health assessments and advanced clinical evaluations across hospitals, diagnostic labs, and research centers. The role of biomarkers in improving clinical workflows and supporting more informed medical decisions continues to grow as laboratory methods become more refined and accessible.

Biomarkers Market Report Highlights

Based on research area, the genomics segment held the leading market position in 2024, primarily due to its extensive application in detecting genetic variations, assessing disease susceptibility, and enabling precision medicine approaches across therapeutic areas.

In terms of technology, the next-generation sequencing technology is anticipated to experience the most rapid market expansion during the forecast period. This accelerated growth reflects NGS's unparalleled capacity for high-throughput genomic analysis, which facilitates comprehensive biomarker discovery

North America captured the largest share of the biomarkers market in 2024, a position supported by the region's concentration of innovative biopharmaceutical firms, advanced diagnostic laboratories, and substantial investments in precision medicine research and development initiatives.

The Asia Pacific biomarkers market is forecast to demonstrate the highest growth rate during the projection period, driven by rapid improvements in healthcare infrastructure, increasing adoption of advanced diagnostic technologies, and expanding capabilities in biomedical research across emerging economies in the region.

A few global key market players include Abbott Laboratories, Agilent Technologies, Inc., BioMerieux SA, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Guardant Health, Inc., Illumina, Inc., Merck KGaA, QIAGEN N.V., Revvity, Inc.

Polaris Market Research has segmented the market report on the basis of type, research area, technology, disease indication, application, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Safety Biomarkers

Efficacy Biomarkers

Validation Biomarkers

By Research Area Outlook (Revenue, USD Billion, 2020-2034)

Genomics

Proteomics

Metabolomics

Other Research Areas

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Immunoassays

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Mass Spectrometry

Chromatography

Other Technologies

By Disease Indication Outlook (Revenue, USD Billion, 2020-2034)

Cancer

Infectious Disease

Immunological Disorders

Neurological Disorders

Cardiovascular Disorders

Other Disease Indications

By Application Outlook (Revenue, USD Billion, 2020-2034)

Clinical Diagnostics

Drug Discovery & Development

Personalized Medicine

Clinical Research

Other Application

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Biomarkers Market Insights

• 4.1. Biomarkers Market - Market Snapshot
• 4.2. Biomarkers Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Prevalence of Chronic Diseases
    • 4.2.1.2. Advancements in Genomics and Proteomics
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High Cost of Biomarker Validation and Development
    • 4.2.2.2. Regulatory Uncertainty and Lengthy Approval Processes
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Biomarkers Market Trends
• 4.6. Value Chain Analysis

5. Global Biomarkers Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Biomarkers Market, by Type, 2020-2034 (USD Billion)
• 5.3. Safety Biomarkers
  • 5.3.1. Global Biomarkers Market, by Safety Biomarkers, by Region, 2020-2034 (USD Billion)
• 5.4. Efficacy Biomarkers
  • 5.4.1.1. Global Biomarkers Market, by Efficacy Biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.4.2. Global Biomarkers Market, by Type, 2020-2034 (USD Billion)
• 5.5. Validation Biomarkers
  • 5.5.1. Global Biomarkers Market, by Validation Biomarkers, by Region, 2020-2034 (USD Billion)

6. Global Biomarkers Market, by Research Area

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
• 6.3. Genomics
  • 6.3.1. Global Biomarkers Market, by Genomics, by Region, 2020-2034 (USD Billion)
• 6.4. Proteomics
  • 6.4.1. Global Biomarkers Market, by Proteomics, by Region, 2020-2034 (USD Billion)
• 6.5. Metabolomics
  • 6.5.1. Global Biomarkers Market, by Metabolomics, by Region, 2020-2034 (USD Billion)
• 6.6. Other Research Areas
  • 6.6.1. Global Biomarkers Market, by Other Research Areas, by Region, 2020-2034 (USD Billion)

7. Global Biomarkers Market, by Technology

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Biomarkers Market, by Technology, 2020-2034 (USD Billion)
• 7.3. Immunoassays
  • 7.3.1. Global Biomarkers Market, by Immunoassays, by Region, 2020-2034 (USD Billion)
• 7.4. Next-Generation Sequencing (NGS)
  • 7.4.1. Global Biomarkers Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
• 7.5. Polymerase Chain Reaction (PCR)
  • 7.5.1. Global Biomarkers Market, by Polymerase Chain Reaction (PCR), by Region, 2020-2034 (USD Billion)
• 7.6. Mass Spectrometry
  • 7.6.1. Global Biomarkers Market, by Mass Spectrometry, by Region, 2020-2034 (USD Billion)
• 7.7. Chromatography
  • 7.7.1. Global Biomarkers Market, by Chromatography, by Region, 2020-2034 (USD Billion)
• 7.8. Other Technologies
  • 7.8.1. Global Biomarkers Market, by Other Technologies, by Region, 2020-2034 (USD Billion)

8. Global Biomarkers Market, by Disease Indication

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
• 8.3. Cancer
  • 8.3.1. Global Biomarkers Market, by Cancer, by Region, 2020-2034 (USD Billion)
• 8.4. Infectious Disease
  • 8.4.1. Global Biomarkers Market, by Infectious Disease, by Region, 2020-2034 (USD Billion)
• 8.5. Immunological Disorders
  • 8.5.1. Global Biomarkers Market, by Immunological Disorders, by Region, 2020-2034 (USD Billion)
• 8.6. Government & Public Sector
  • 8.6.1. Global Biomarkers Market, by Government & Public Sector, by Region, 2020-2034 (USD Billion)
• 8.7. Neurological Disorders
  • 8.7.1. Global Biomarkers Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
• 8.8. Cardiovascular Disorders
  • 8.8.1. Global Biomarkers Market, by Cardiovascular Disorders, by Region, 2020-2034 (USD Billion)
• 8.9. Other Disease Indications
  • 8.9.1. Global Biomarkers Market, by Other Disease Indications, by Region, 2020-2034 (USD Billion)

9. Global Biomarkers Market, by Application

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 9.3. Clinical Diagnostics
  • 9.3.1. Global Biomarkers Market, by Clinical Diagnostics, by Region, 2020-2034 (USD Billion)
• 9.4. Drug Discovery & Development
  • 9.4.1. Global Biomarkers Market, by Drug Discovery & Development, by Region, 2020-2034 (USD Billion)
• 9.5. Personalized Medicine
  • 9.5.1. Global Biomarkers Market, by Personalized Medicine, by Region, 2020-2034 (USD Billion)
• 9.6. Clinical Research
  • 9.6.1. Global Biomarkers Market, by Clinical Research, by Region, 2020-2034 (USD Billion)
• 9.7. Other Application
  • 9.7.1. Global Biomarkers Market, by Other Application, by Region, 2020-2034 (USD Billion)

10. Global Biomarkers Market, by Geography

• 10.1. Key Findings
• 10.2. Introduction
  • 10.2.1. Biomarkers Market Assessment, By Geography, 2020-2034 (USD Billion)
• 10.3. Biomarkers Market - North America
  • 10.3.1. North America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 10.3.2. North America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • 10.3.3. North America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • 10.3.4. North America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • 10.3.5. North America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.3.6. Biomarkers Market - U.S.
    • 10.3.6.1. U.S.: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.3.6.2. U.S.: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.3.6.3. U.S.: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.3.6.4. U.S.: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.3.6.5. U.S.: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.3.7. Biomarkers Market - Canada
    • 10.3.7.1. Canada: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.3.7.2. Canada: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.3.7.3. Canada: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.3.7.4. Canada: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.3.7.5. Canada: Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 10.4. Biomarkers Market - Europe
  • 10.4.1. Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 10.4.2. Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • 10.4.3. Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • 10.4.4. Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • 10.4.5. Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.4.6. Biomarkers Market - UK
    • 10.4.6.1. UK: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.4.6.2. UK: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.4.6.3. UK: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.6.4. UK: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.6.5. UK: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.4.7. Biomarkers Market - France
    • 10.4.7.1. France: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.4.7.2. France: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.4.7.3. France: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.7.4. France: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.7.5. France: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.4.8. Biomarkers Market - Germany
    • 10.4.8.1. Germany: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.4.8.2. Germany: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.4.8.3. Germany: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.8.4. Germany: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.8.5. Germany: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.4.9. Biomarkers Market - Italy
    • 10.4.9.1. Italy: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.4.9.2. Italy: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.4.9.3. Italy: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.9.4. Italy: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.9.5. Italy: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.4.10. Biomarkers Market - Spain
    • 10.4.10.1. Spain: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.4.10.2. Spain: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.4.10.3. Spain: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.10.4. Spain: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.10.5. Spain: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.4.11. Biomarkers Market - Netherlands
    • 10.4.11.1. Netherlands: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.4.11.2. Netherlands: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.4.11.3. Netherlands: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.11.4. Netherlands: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.11.5. Netherlands: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.4.12. Biomarkers Market - Russia
    • 10.4.12.1. Russia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.4.12.2. Russia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.4.12.3. Russia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.12.4. Russia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.12.5. Russia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.4.13. Biomarkers Market - Rest of Europe
    • 10.4.13.1. Rest of Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.4.13.2. Rest of Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.4.13.3. Rest of Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.13.4. Rest of Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.13.5. Rest of Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 10.5. Biomarkers Market - Asia Pacific
  • 10.5.1. Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 10.5.2. Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • 10.5.3. Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • 10.5.4. Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • 10.5.5. Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.5.6. Biomarkers Market - China
    • 10.5.6.1. China: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.5.6.2. China: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.5.6.3. China: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.6.4. China: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.6.5. China: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.5.7. Biomarkers Market - India
    • 10.5.7.1. India: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.5.7.2. India: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.5.7.3. India: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.7.4. India: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.7.5. India: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.5.8. Biomarkers Market - Malaysia
    • 10.5.8.1. Malaysia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.5.8.2. Malaysia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.5.8.3. Malaysia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.8.4. Malaysia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.8.5. Malaysia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.5.9. Biomarkers Market - Japan
    • 10.5.9.1. Japan: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.5.9.2. Japan: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.5.9.3. Japan: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.9.4. Japan: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.9.5. Japan: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.5.10. Biomarkers Market - Indonesia
    • 10.5.10.1. Indonesia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.5.10.2. Indonesia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.5.10.3. Indonesia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.10.4. Indonesia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.10.5. Indonesia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.5.11. Biomarkers Market - South Korea
    • 10.5.11.1. South Korea: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.5.11.2. South Korea: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.5.11.3. South Korea: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.11.4. South Korea: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.11.5. South Korea: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.5.12. Biomarkers Market - Australia
    • 10.5.12.1. Australia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.5.12.2. Australia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.5.12.3. Australia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.12.4. Australia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.12.5. Australia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.5.13. Biomarkers Market - Rest of Asia Pacific
    • 10.5.13.1. Rest of Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.5.13.2. Rest of Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.5.13.3. Rest of Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.13.4. Rest of Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.13.5. Rest of Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 10.6. Biomarkers Market - Middle East & Africa
  • 10.6.1. Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 10.6.2. Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • 10.6.3. Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • 10.6.4. Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • 10.6.5. Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.6.6. Biomarkers Market - Saudi Arabia
    • 10.6.6.1. Saudi Arabia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.6.6.2. Saudi Arabia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.6.6.3. Saudi Arabia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.6.6.4. Saudi Arabia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.6.5. Saudi Arabia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.6.7. Biomarkers Market - UAE
    • 10.6.7.1. UAE: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.6.7.2. UAE: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.6.7.3. UAE: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.6.7.4. UAE: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.7.5. UAE: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.6.8. Biomarkers Market - Israel
    • 10.6.8.1. Israel: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.6.8.2. Israel: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.6.8.3. Israel: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.6.8.4. Israel: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.8.5. Israel: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.6.9. Biomarkers Market - South Africa
    • 10.6.9.1. South Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.6.9.2. South Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.6.9.3. South Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.6.9.4. South Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.9.5. South Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.6.10. Biomarkers Market - Rest of Middle East & Africa
    • 10.6.10.1. Rest of Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.6.10.2. Rest of Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.6.10.3. Rest of Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.6.10.4. Rest of Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.10.5. Rest of Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
• 10.7. Biomarkers Market - Latin America
  • 10.7.1. Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 10.7.2. Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • 10.7.3. Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • 10.7.4. Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • 10.7.5. Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.7.6. Biomarkers Market - Mexico
    • 10.7.6.1. Mexico: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.7.6.2. Mexico: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.7.6.3. Mexico: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.7.6.4. Mexico: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.6.5. Mexico: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.7.7. Biomarkers Market - Brazil
    • 10.7.7.1. Brazil: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.7.7.2. Brazil: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.7.7.3. Brazil: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.7.7.4. Brazil: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.7.5. Brazil: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.7.8. Biomarkers Market - Argentina
    • 10.7.8.1. Argentina: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.7.8.2. Argentina: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.7.8.3. Argentina: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.7.8.4. Argentina: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.8.5. Argentina: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.7.9. Biomarkers Market - Rest of Latin America
    • 10.7.9.1. Rest of Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.7.9.2. Rest of Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.7.9.3. Rest of Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.7.9.4. Rest of Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.9.5. Rest of Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)

11. Competitive Landscape

• 11.1. Expansion and Acquisition Analysis
  • 11.1.1. Expansion
  • 11.1.2. Acquisitions
• 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

• 12.1. Abbott Laboratories
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Benchmarking
  • 12.1.4. Recent Development
• 12.2. Agilent Technologies, Inc.
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Benchmarking
  • 12.2.4. Recent Development
• 12.3. BioMerieux SA
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Benchmarking
  • 12.3.4. Recent Development
• 12.4. Bio-Rad Laboratories, Inc.
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Benchmarking
  • 12.4.4. Recent Development
• 12.5. Charles River Laboratories International, Inc.
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Benchmarking
  • 12.5.4. Recent Development
• 12.6. Eurofins Scientific SE
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Benchmarking
  • 12.6.4. Recent Development
• 12.7. F. Hoffmann-La Roche Ltd
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Benchmarking
  • 12.7.4. Recent Development
• 12.8. Guardant Health, Inc.
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Benchmarking
  • 12.8.4. Recent Development
• 12.9. Illumina, Inc.
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Benchmarking
  • 12.9.4. Recent Development
• 12.10. Merck KGaA
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Benchmarking
  • 12.10.4. Recent Development
• 12.11. QIAGEN N.V.
  • 12.11.1. Company Overview
  • 12.11.2. Financial Performance
  • 12.11.3. Product Benchmarking
  • 12.11.4. Recent Development
• 12.12. Revvity, Inc.
  • 12.12.1. Company Overview
  • 12.12.2. Financial Performance
  • 12.12.3. Product Benchmarking
  • 12.12.4. Recent Development

관련자료